Evidence map›Paper›PMID 38819482›Full record

ReviewApplied microbiology and biotechnology2024

Enzymes for production of whey protein hydrolysates and other value-added products.

José Matías Irazoqui, Gonzalo Manuel Santiago, María Esperanza Mainez, Ariel Fernando Amadio, María Florencia Eberhardt

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

José Matías IrazoquiInstituto de Investigación de La Cadena Láctea (CONICET-INTA), 2300, Rafaela, Argentina.
Gonzalo Manuel SantiagoInstituto de Investigación de La Cadena Láctea (CONICET-INTA), 2300, Rafaela, Argentina.
María Esperanza MainezInstituto de Investigación de La Cadena Láctea (CONICET-INTA), 2300, Rafaela, Argentina.
Ariel Fernando AmadioInstituto de Investigación de La Cadena Láctea (CONICET-INTA), 2300, Rafaela, Argentina.
María Florencia EberhardtInstituto de Investigación de La Cadena Láctea (CONICET-INTA), 2300, Rafaela, Argentina. eberhardt.maria@inta.gob.ar.ORCID http://orcid.org/0000-0001-8456-0555

Funding

Fondo para la Investigación Científica y Tecnológica 2018-4396
6 · The paper itself

Abstract

Whey is a byproduct of dairy industries, the aqueous portion which separates from cheese during the coagulation of milk. It represents approximately 85-95% of milk's volume and retains much of its nutrients, including functional proteins and peptides, lipids, lactose, minerals, and vitamins. Due to its composition, mainly proteins and lactose, it can be considered a raw material for value-added products. Whey-derived products are often used to supplement food, as they have shown several physiological effects on the body. Whey protein hydrolysates are reported to have different activities, including antihypertensive, antioxidant, antithrombotic, opioid, antimicrobial, cytomodulatory, and immuno-modulatory. On the other hand, galactooligosaccharides obtained from lactose can be used as prebiotic for beneficial microorganisms for the human gastrointestinal tract. All these compounds can be obtained through physicochemical, microbial, or enzymatic treatments. Particularly, enzymatic processes have the advantage of being highly selective, more stable than chemical transformations, and less polluting, making that the global enzyme market grow at accelerated rates. The sources and different products associated with the most used enzymes are particularly highlighted in this review. Moreover, we discuss metagenomics as a tool to identify novel proteolytic enzymes, from both cultivable and uncultivable microorganisms, which are expected to have new interesting activities. Finally enzymes for the transformation of whey sugar are reviewed. In this sense, carbozymes with ß-galactosidase activity are capable of lactose hydrolysis, to obtain free monomers, and transgalactosylation for prebiotics production. KEY POINTS: • Whey can be used to obtain value-added products efficiently through enzymatic treatments • Proteases transform whey proteins into biopeptides with physiological activities • Lactose can be transformed into prebiotic compounds using ß-galactosidases.

Indexed as

Protein HydrolysatesWhey Proteinsbeta-GalactosidaseHumansLactosePrebioticsWheybeta-GalactosidaseLactosePrebioticsProtein HydrolysatesWhey ProteinsBiopeptidesEnzymesGalactooligosaccharidesWhey proteasesβ-galactosidases

Identifiers

PMID38819482
PMCPMC11142983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.